Silence Therapeutics plc (SLN) Insider Trading Activity

NASDAQ$19.785
Market Cap
$934.29M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
772 of 849
Rank in Industry
444 of 491

SLN Insider Trading Activity

SLN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$104,138,993
6
100

Related Transactions

Griffiths Richard Ian10 percent owner
0
$0
6
$104.14M
$-104.14M

About Silence Therapeutics plc

Silence Therapeutics plc is a London, UK-based biotechnology company specializing in the research and development of groundbreaking ribonucleic acid (RNA) therapeutics. Its therapeutic focus areas include hematological, cardiovascular, and various rare and metabolic conditions. Central to their innovative approach is the mRNAi GalNAc Oligonucleotide Discovery platform, which is designed for precise targeting of specific disease-causing genes within the liver. The company's methodology harnesses the body's natural RNA interference (RNAi) …

Insider Activity of Silence Therapeutics plc

Over the last 12 months, insiders at Silence Therapeutics plc have bought $0 and sold $104.14M worth of Silence Therapeutics plc stock.

On average, over the past 5 years, insiders at Silence Therapeutics plc have bought $11.68M and sold $52.13M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,000 shares for transaction amount of $15,500 was made by Griffiths Richard Ian (10 percent owner) on 2025‑10‑27.

List of Insider Buy and Sell Transactions, Silence Therapeutics plc

2026-08-10SaleGriffiths Richard Ian10 percent owner
5.48M
12.0429%
$16.00
$87.78M
-13.38%
2026-07-06SaleGriffiths Richard Ian10 percent owner
865,112
1.8229%
$10.53
$9.11M
+15.31%
2026-07-02SaleGriffiths Richard Ian10 percent owner
50,082
0.1068%
$10.47
$524,359
+16.80%
2026-07-01SaleGriffiths Richard Ian10 percent owner
129,180
0.2766%
$10.62
$1.37M
+14.95%
2026-06-30SaleGriffiths Richard Ian10 percent owner
169,928
0.3525%
$10.76
$1.83M
+9.38%
2026-06-29SaleGriffiths Richard Ian10 percent owner
330,072
0.6923%
$10.69
$3.53M
+10.75%
2025-10-27SaleGriffiths Richard Ian10 percent owner
2,000
0.0057%
$7.75
$15,500
-3.36%
2025-10-27PurchaseGriffiths Richard Ian10 percent owner
2,000
0.0057%
$7.75
$15,500
-3.36%
2025-08-03SaleGriffiths Richard Ian10 percent owner
20,000
0.0399%
$5.45
$109,000
+4.71%
2025-08-03PurchaseGriffiths Richard Ian10 percent owner
20,000
0.0399%
$5.45
$109,000
+4.71%
2025-08-01PurchaseGriffiths Richard Ian10 percent owner
4,034
0.0091%
$6.14
$24,769
+0.97%
2025-07-31PurchaseGriffiths Richard Ian10 percent owner
14,342
0.0324%
$6.18
$88,634
+1.14%
2025-07-30PurchaseGriffiths Richard Ian10 percent owner
8,923
0.0201%
$6.14
$54,787
+1.30%
2025-07-29PurchaseGriffiths Richard Ian10 percent owner
14,559
0.033%
$6.20
$90,266
0.00%
2025-07-22PurchaseGriffiths Richard Ian10 percent owner
2,910
0.0065%
$6.09
$17,722
-0.80%
2025-07-21PurchaseGriffiths Richard Ian10 percent owner
22,435
0.0496%
$6.04
$135,507
+0.49%
2025-07-15PurchaseGriffiths Richard Ian10 percent owner
43,293
0.1014%
$6.40
$277,075
-4.93%
2025-07-11PurchaseGriffiths Richard Ian10 percent owner
28,000
0.0659%
$6.43
$180,040
-4.19%
2025-07-09PurchaseGriffiths Richard Ian10 percent owner
30,133
0.0662%
$6.00
$180,798
-4.78%
2025-07-08PurchaseGriffiths Richard Ian10 percent owner
24,387
0.053%
$5.94
$144,859
+4.40%
Total: 66
*Gray background shows transactions not older than one year

Insider Historical Profitability

32.2%
Griffiths Richard Ian10 percent owner
4797166
10.1562%
$94.89M588
+32.2%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$831,902,292
108
9.34%
$1.2B
$100,473,344
83
9.53%
$826.91M
$15,410,062
81
39.69%
$975.93M
$5,911,307
70
-1.38%
$884.8M
Silence Therapeutics plc
(SLN)
$11,663,618
57
32.20%
$934.29M

SLN Institutional Investors: Active Positions

Increased Positions29+42.65%3M+15.62%
Decreased Positions28-41.18%5M-25.48%
New Positions14New2MNew
Sold Out Positions11Sold Out2MSold Out
Total Postitions69+1.47%18M-9.86%

SLN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.